The medicines of Samarra achieve an increase in the value of its production program, exceeding five billion
08:54 - 12/12/2019
[You must be registered and logged in to see this link.]
The General Company for the manufacture of medicines and medical supplies in Samarra, one of the companies of the Ministry of Industry and Minerals, announced, on Thursday, that it achieved a significant increase in the production value of (5) billion and (919) million dinars for the past four months (July, August, September, October) this year compared to the same period last year 2018.
The general manager of the pharmaceutical company, Abdel Hamid Abdel Rahman Al Salem, said in a statement seen by the information: “The company achieved a production value of more than (15) billion dinars for the months of July to October of the current year 2019 compared to more than (9) billion for the period The same from last year 2018, an increase of more than (5) billion dinars.
Al-Salem added, "The realization of this increase confirms that the company is progressing steadily towards the development of production and marketing through the plans it has put in place in this regard." Ended / 25